Orthopaedic Surgery in Fair Lawn, NJ
10 verified orthopaedic surgery doctors in Fair Lawn.
Orthopedic surgeons diagnose and treat conditions of the bones, joints, ligaments, tendons, and muscles.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the New Jersey State Board of Medical Examiners
Dr. Samuel Snyder, MD
Orthopaedic Surgery
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Kenneth Levitsky, MD
Orthopaedic Surgery
CMS Open Payments· $169.21 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$169.21
Total received
3
Transactions
2
Paying companies
Top paying companies
Among the 28,855 orthopaedic surgery doctors we've analyzed, about 64% received any industry payment (median $545 among those who did). This doctor's total ranks around the 55th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US orthopaedic surgery doctors.
Payments to Kenneth Levitsky do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Douglas Holden, MD
Orthopaedic Surgery
CMS Open Payments· $623.04 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$623.04
Total received
15
Transactions
7
Paying companies
Top paying companies
Among the 28,855 orthopaedic surgery doctors we've analyzed, about 64% received any industry payment (median $545 among those who did). This doctor's total ranks around the 70th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US orthopaedic surgery doctors.
Payments to Douglas Holden do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Adam Bernstein, MD
Orthopaedic Surgery
CMS Open Payments· $40.70 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$40.70
Total received
2
Transactions
1
Paying companies
Top paying companies
Among the 28,855 orthopaedic surgery doctors we've analyzed, about 64% received any industry payment (median $545 among those who did). This doctor's total is on the lower end — around the 43th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US orthopaedic surgery doctors.
Payments to Adam Bernstein do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Brian Vangrouw, DO
Orthopaedic Surgery
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. David Gold, MD
Orthopaedic Surgery
CMS Open Payments· $80.92 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$80.92
Total received
2
Transactions
1
Paying companies
Top paying companies
Among the 28,855 orthopaedic surgery doctors we've analyzed, about 64% received any industry payment (median $545 among those who did). This doctor's total is on the lower end — around the 47th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US orthopaedic surgery doctors.
Payments to David Gold do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Vivek Natarajan, MD
Orthopaedic Surgery
CMS Open Payments· $36.78 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$36.78
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 28,855 orthopaedic surgery doctors we've analyzed, about 64% received any industry payment (median $545 among those who did). This doctor's total is on the lower end — around the 42th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US orthopaedic surgery doctors.
Payments to Vivek Natarajan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Ryan Cassilly, MD
Orthopaedic Surgery
CMS Open Payments· $327.13 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$327.13
Total received
5
Transactions
4
Paying companies
Top paying companies
Among the 28,855 orthopaedic surgery doctors we've analyzed, about 64% received any industry payment (median $545 among those who did). This doctor's total ranks around the 63th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US orthopaedic surgery doctors.
Payments to Ryan Cassilly do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Charles Ekstein, MD
Orthopaedic Surgery
CMS Open Payments· $135.52 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$135.52
Total received
7
Transactions
5
Paying companies
Top paying companies
Among the 28,855 orthopaedic surgery doctors we've analyzed, about 64% received any industry payment (median $545 among those who did). This doctor's total ranks around the 52th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US orthopaedic surgery doctors.
Payments to Charles Ekstein do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Noah Kirschner, MD
Orthopaedic Surgery
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.